-
Mashup Score: 5From rapid cooling body bags to 'prescriptions’ for AC, doctors prepare for a future of extreme heat - 2 year(s) ago
From body bags for rapid cooling to “prescriptions” for air conditioners, doctors are preparing for a future of extreme heat linked to climate change.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 8Hearing aids may slow mental decline in those at higher risk of dementia, study finds - 2 year(s) ago
New research ties hearing aids to slower cognitive decline in those at higher risk of dementia.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Doctors have long suspected that hearing loss in older adults accelerates dementia. A new study draws more on that theory. https://t.co/fDNjYm7AfL
-
-
Mashup Score: 0Johnson & Johnson sues to stop Medicare negotiation - 2 year(s) ago
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program. https://t.co/t3moZImiIY
-
-
Mashup Score: 9
“GPT-4, being trained off of our own textual communication, shows the same — or maybe even more exaggerated — racial and sex biases as humans” in health care.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
“GPT-4, being trained off of our own textual communication, shows the same — or maybe even more exaggerated — racial and sex biases as humans" in health care. https://t.co/B49Z8MnocW
-
-
Mashup Score: 3Flagship, Pfizer team up in deal worth up to $7 billion - 2 year(s) ago
The new Pfizer partnership with Flagship will fund the development of up to 10 drug candidates.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
The new Pfizer partnership with Flagship will fund the development of up to 10 drug candidates. https://t.co/jdcNkcWkGa
-
-
Mashup Score: 0STAT Virtual Event: The State of Biosimilars: What to Watch - 2 year(s) ago
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
HAPPENING NOW: Join our #STATVirtual event on the state of biosimilars. https://t.co/1rjmKXF14D
-
-
Mashup Score: 0
“Increasingly, I think patients, health insurers, providers and even investors are really saying, ‘How do we make sure digital health tools work, and what does work even mean?’ “
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
As digital health tech proliferates, a new institute aims to cut through hype https://t.co/rybCtLcaME via @statnews
-
-
Mashup Score: 0From rapid cooling body bags to 'prescriptions’ for AC, doctors prepare for a future of extreme heat - 2 year(s) ago
From body bags for rapid cooling to “prescriptions” for air conditioners, doctors are preparing for a future of extreme heat linked to climate change.
Source: STATCategories: Cardiologists, Latest HeadlinesTweet-
Phoenix is expecting to top 110 degrees again today, setting a new record for consecutive days above 110. Meanwhile, health professionals in the Southwest are preparing with ice-filled "body bags". https://t.co/0cHrsHSx2L
-
-
Mashup Score: 0Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing - 2 year(s) ago
For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing.. read the case reports here.. https://t.co/AWWUJ1IFCL #pharma #Entresto #heartfailure $NVS $NVO
-
-
Mashup Score: 2Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing - 2 year(s) ago
For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug. https://t.co/ymhm7tpUVX
-
It's hot out there. From immersive cooling body bags to ‘prescriptions’ for air conditioning, here's how doctors are preparing to deal with a future of extreme heat. https://t.co/GHkJyDHVXM